Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 282,021 | 228,122 | 211,822 | 222,503 | 222,969 |
| Marketable Securities | 93,527 | 76,430 | 65,852 | 57,812 | 61,476 |
| Receivables | 107,132 | 106,836 | 95,852 | 78,286 | 68,530 |
| Inventories | 24,021 | 22,941 | 22,418 | 22,403 | 21,594 |
| TOTAL | $530,575 | $453,398 | $410,818 | $392,788 | $386,626 |
| Non-Current Assets | |||||
| PPE Net | 1,277 | 1,177 | 1,108 | 1,139 | 1,212 |
| Investments And Advances | 2,470 | 17,112 | 20,912 | 12,526 | 9,321 |
| Intangibles | 231,895 | 237,870 | 243,845 | 249,819 | 255,794 |
| Other Non-Current Assets | 18,898 | 16,268 | 13,562 | 14,482 | 14,940 |
| TOTAL | $254,540 | $272,427 | $279,427 | $277,966 | $281,267 |
| Total Assets | $785,115 | $725,825 | $690,245 | $670,754 | $667,893 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,167 | 17,657 | 11,639 | 14,618 | 9,545 |
| Accrued Expenses | 148,192 | 127,139 | 115,938 | 111,933 | 104,700 |
| TOTAL | $160,359 | $144,796 | $127,577 | $126,551 | $115,751 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 332,710 | 325,871 | 329,412 | 318,563 | 320,118 |
| TOTAL | $332,710 | $325,871 | $329,412 | $318,563 | $320,118 |
| Total Liabilities | $493,069 | $470,667 | $456,989 | $445,114 | $435,869 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,394 | 50,238 | 49,535 | 49,014 | 48,005 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -661,814 | -664,719 | -658,858 | -644,181 | -620,391 |
| Other shareholders' equity | 37 | 352 | -258 | -373 | 920 |
| TOTAL | $292,046 | $255,158 | $233,256 | $225,640 | $232,024 |
| Total Liabilities And Equity | $785,115 | $725,825 | $690,245 | $670,754 | $667,893 |